FDA Inspection 1077019 — Kaplan, Andrew J MD
The FDA completed an inspection of Kaplan, Andrew J MD on Jan 10, 2019 in Mesa, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 10, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Mesa, AZ (United States)
Additional Details
Clinical Investigator (CI)